Cellect Biotechnology logo

APOP - Cellect Biotechnology News Story

$3.17 0.0  0.3%

Last Trade - 22/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £5.28m
Enterprise Value £805k
Revenue £n/a
Position in Universe 6152nd / 6630

BRIEF-Cellect Biotechnology Reports Q1 Loss Per Share Of $0.002

Thu 21st May, 2020 9:04pm
May 21 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY REPORTS FIRST QUARTER 2020 FINANCIAL
AND
OPERATING RESULTS; CONTINUES TO DEMONSTRATE SIGNIFICANT PROGRESS
DESPITE ADJUSTED OPERATIONS DUE TO COVID-19
    * Q1 LOSS PER SHARE $0.002
    * COMPANY'S CASH AND CASH EQUIVALENTS TOTALED $7.08 MILLION
AS OF
MARCH 31, 2020

Source text for Eikon:  ID:nGNX7g9S2S 
Further company coverage:  APOP.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.